Data from human genetic studies have demonstrated that loss-of-function mutations in the Angptl4 locus are linked to reduced type 2 diabetes and risk of cardiovascular disease (54, 64–68). The gene discussed is ANGPTL4; the disease is type 2 diabetes mellitus.